HS-10381
/ Jiangsu Hansoh Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
July 07, 2022
A PhaseⅠStudy of HS-10381 in Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=51 | Recruiting | Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Oncology • Solid Tumor
May 18, 2022
A PhaseⅠStudy of HS-10381 in Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=51 | Not yet recruiting | Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
New P1 trial • Oncology • Solid Tumor
1 to 2
Of
2
Go to page
1